Holen Sie sich die Stockscreener-App
21.77
4.68%
-1.07
Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten
Janux Therapeutics stock hits 52-week low at 21.97 USD - Investing.com
Janux Therapeutics (NASDAQ:JANX) Coverage Initiated by Analysts at Barclays - MarketBeat
Top 5 Oncology Stocks to Watch According to Barclays By Investing.com - Investing.com Canada
Janux Therapeutics (NASDAQ:JANX) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Janux Therapeutics (NASDAQ:JANX) Shares Gap UpTime to Buy? - MarketBeat
Institution Moves: Will Denison Mines Corp stock benefit from M A2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک
Janux Therapeutics Announces Departure of Chief Strategy Officer - The Globe and Mail
Janux Therapeutics chief strategy officer departs in company-initiated move By Investing.com - Investing.com Nigeria
Janux Therapeutics chief strategy officer departs in company-initiated move - Investing.com
Big Money Moves: Is Janux Therapeutics Inc. stock a buy or sell2025 Analyst Calls & Technical Pattern Based Signals - khodrobank.com
Janux Therapeutics, Inc. $JANX Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Momentum Shift: Is MGRM forming bullish engulfing patternsCEO Change & Free Expert Verified Stock Movement Alerts - khodrobank.com
Aug Closing: Can Janux Therapeutics Inc generate free cash flowPortfolio Return Report & Real-Time Stock Entry Alerts - khodrobank.com
US Market Wrap: Whats the fair value of Achieve Life Sciences Inc stockChart Signals & Smart Investment Allocation Tips - khodrobank.com
Aug Ideas: Is NetApp Inc subject to activist investor interestQuarterly Trade Review & Weekly Watchlist for Consistent Profits - خودرو بانک
Investment Review: What is Janux Therapeutics Incs valuation compared to sectorOil Prices & Free Verified High Yield Trade Plans - خودرو بانک
Momentum Shift: Should you avoid CBFV stock right nowMarket Performance Report & Risk Controlled Swing Trade Alerts - خودرو بانک
Barclays Initiates Coverage on JANX with Overweight Rating | JAN - GuruFocus
Barclays Initiates Coverage of Janux Therapeutics (JANX) with Overweight Recommendation - Nasdaq
Bernstein Initiates Janux Therapeutics at Overweight With $47 Price Target - MarketScreener
Janux Therapeutics initiated with an Overweight at Barclays - TipRanks
Highs Report: Is HCKT forming bullish engulfing patternsMarket Trend Report & Expert Verified Movement Alerts - خودرو بانک
Aug Swings: Should I hold or sell INNOVATE Corp. Equity Right now2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - khodrobank.com
Market Fear: What is Janux Therapeutics Incs valuation compared to sectorWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT - Yahoo Finance
Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Truist Financial - MarketBeat
Woodline Partners LP Has $39.34 Million Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat
Janux Therapeutics Inc. recovery potential after sell off2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Analyzing recovery setups for Janux Therapeutics Inc. investorsWeekly Risk Report & Fast Exit Strategy with Risk Control - newser.com
Statistical indicators supporting Janux Therapeutics Inc.’s strengthTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Visualizing Janux Therapeutics Inc. stock with heatmaps2025 Price Targets & Smart Money Movement Alerts - newser.com
Comparing Janux Therapeutics Inc. in custom built stock radars2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
How hedge fund analytics apply to Janux Therapeutics Inc. stockExit Point & Weekly Momentum Picks - newser.com
10 Best Up and Coming Stocks with Huge Upside Potential - Insider Monkey
Institutional scanner results for Janux Therapeutics Inc.Market Risk Analysis & High Conviction Investment Ideas - newser.com
Short interest data insights for Janux Therapeutics Inc.Take Profit & Intraday High Probability Setup Alerts - Newser
Cubist Systematic Strategies LLC Has $2.05 Million Position in Janux Therapeutics, Inc. $JANX - MarketBeat
Bank of America Securities Remains a Buy on Janux Therapeutics Inc (JANX) - The Globe and Mail
Possible Bearish Signals With Janux Therapeutics Insiders Disposing Stock - 富途牛牛
Stifel Nicolaus Reaffirms “Buy” Rating for Janux Therapeutics (NASDAQ:JANX) - Defense World
BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛
Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Guggenheim - MarketBeat
Alyeska Investment Group L.P. Purchases 63,762 Shares of Janux Therapeutics, Inc. $JANX - MarketBeat
Janux stock a new Buy at Truist on H2 catalysts (JANX:NASDAQ) - Seeking Alpha
Truist Initiates Janux Therapeutics at Buy With $100 Price Target - MarketScreener
Janux Therapeutics initiated with a Buy at Truist - TipRanks
Buy Rating for Janux Therapeutics Inc: Promising Oncology Innovations and Strategic Advancements - TipRanks
Janux Therapeutics resumed with a Buy at Stifel - TipRanks
Stifel resumes Janux Therapeutics stock coverage with Buy rating By Investing.com - Investing.com Canada
Walleye Capital LLC Makes New Investment in Janux Therapeutics, Inc. $JANX - MarketBeat
Analysts Set Janux Therapeutics, Inc. (NASDAQ:JANX) PT at $86.90 - MarketBeat
Adage Capital Partners GP L.L.C. Purchases 592,824 Shares of Janux Therapeutics, Inc. $JANX - MarketBeat
Technical Charts Suggest Momentum Shift in Janux Therapeutics Inc.2025 Biggest Moves & Verified Momentum Watchlists - beatles.ru
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):